GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (OTCPK:HYPMY) » Definitions » Median PS Value

HYPMY (Hypera) Median PS Value : $10.63 (As of Apr. 07, 2025)


View and export this data going back to . Start your Free Trial

What is Hypera Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Hypera's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $2.144. Hypera's 10-Year median PS Ratio is 4.958. Therefore, the Median PS Value for today is $10.63.

As of today (2025-04-07), Hypera's share price is $3.59. Hypera's Median PS Value is $10.63. Therefore, Hypera's Price to Median PS Value for today is 0.34.

The historical rank and industry rank for Hypera's Median PS Value or its related term are showing as below:

HYPMY' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.3   Med: 0.74   Max: 1.48
Current: 0.34

During the past 13 years, the highest Price to Median PS Value of Hypera was 1.48. The lowest was 0.30. And the median was 0.74.

HYPMY's Price-to-Median-PS-Value is ranked better than
89.66% of 503 companies
in the Drug Manufacturers industry
Industry Median: 0.86 vs HYPMY: 0.34

Hypera Median PS Value Historical Data

The historical data trend for Hypera's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypera Median PS Value Chart

Hypera Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.10 8.46 11.32 12.82 10.19

Hypera Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.82 13.22 11.84 11.84 10.19

Competitive Comparison of Hypera's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, Hypera's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hypera's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hypera's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Hypera's Price-to-Median-PS-Value falls into.


;
;

Hypera Median PS Value Calculation

Hypera's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=2.144*4.958
=10.63

10-Year Median PS Ratio is 4.958.
Hypera's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.144.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hypera  (OTCPK:HYPMY) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Hypera's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=3.59/10.63
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hypera Median PS Value Related Terms

Thank you for viewing the detailed overview of Hypera's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Hypera Business Description

Traded in Other Exchanges
Address
Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120
Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and Non-Retail Market.

Hypera Headlines

From GuruFocus

Hypera SA's Dividend Analysis

By GuruFocus Research 03-22-2024

Q3 2019 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2019 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2020 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2024 Hypera SA Earnings Call Transcript

By GuruFocus News 10-09-2024

Q3 2020 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Bestinfond's Top 6 Buys in 2nd Quarter

By James Li James Li 08-08-2018

Q3 2022 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2020 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2021 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024